A Canada-based investment group formed by successful entrepreneurs seeks to invest globally in small-to-mid sized medical device and pharmaceutical companies. The firm can act as a co-investor or lead, and can leverage distribution networks and partnerships across 4 continents. Typical allocations are < $25 M structured as equity, and may come from a combination of the firm’s fund, partners’ personal funds, or a family office whose wealth is managed by the firm. Portfolio companies focus on specialty pharmaceuticals, biotechnology, medical devices, & ancillary health services.
The firm’s specialty area is in generic pharmaceutical manufacturing and distribution, and manufacturing and distribution of specialty medical devices. Urology and urogynecology devices, injectable medications, cardiovascular medications, dental devices, vaccines, oncology therepeutics, diagnostics, and surgical simulators are reflected in portfolio companies. Devices that fit well in the focus and distribution regions of portfolio companies are of particular interest.
The firm looks for strong & accomplished management teams and above all, values, innovation, transparency, integrity, and execution. The firm may or may not seek a board seat depending on the structure of the allocation.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment